Media Centre
Latest press releases
-
Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years
-
Lynparza improved the time women lived without disease progression to 22 months in the broad population and to 37 months in HRD-positive patients as 1st-line maintenance treatment with bevacizumab for newly-diagnosed advanced ovarian cancer
-
AstraZeneca to present next wave of science in respiratory disease at ERS International Congress
-
Qtrilmet recommended for approval in EU by CHMP for the treatment of type-2 diabetes
-
AstraZeneca amends collaboration with Ironwood for Linzess in China
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
